NIKA PHARMACEUTICALS, INC financial data

Symbol
NIKA on OTC
Location
Henderson, NV
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10% % -57%
Debt-to-equity -111% % 34%
Return On Equity 24% % -58%
Return On Assets -216% % -140%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,039,836,001 shares 2.1%
Common Stock, Shares, Outstanding 1,039,836,001 shares 2.1%
Entity Public Float $0 USD
Common Stock, Value, Issued $103,964 USD 2.1%
Weighted Average Number of Shares Outstanding, Basic 1,026,406,001 shares 0.77%
Weighted Average Number of Shares Outstanding, Diluted 1,039,836,001 shares 2.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $156 USD
General and Administrative Expense $32,921 USD -30%
Operating Income (Loss) $58,341 USD 43%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $58,341 USD 43%
Net Income (Loss) Attributable to Parent $58,341 USD 43%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,287 USD 354%
Accounts Receivable, after Allowance for Credit Loss, Current $196,394 USD
Inventory, Net $14,104 USD
Assets, Current $23,625 USD 1605%
Property, Plant and Equipment, Net $168,259 USD
Assets $23,625 USD 1605%
Liabilities, Current $284,164 USD 35%
Liabilities $284,164 USD 35%
Retained Earnings (Accumulated Deficit) $8,966,920 USD -0.58%
Stockholders' Equity Attributable to Parent $260,539 USD -30%
Liabilities and Equity $23,625 USD 1605%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,945 USD 85%
Net Cash Provided by (Used in) Financing Activities $30,000 USD -70%
Common Stock, Shares Authorized 2,700,000,000 shares 0%
Common Stock, Shares, Issued 1,039,836,001 shares 2.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $17,054 USD 16%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,287 USD 354%
Deferred Tax Assets, Valuation Allowance $1,878,127 USD 163%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $7,999 USD 4.4%
Deferred Tax Assets, Operating Loss Carryforwards $1,878,127 USD 163%
Preferred Stock, Shares Issued 15,000,000 shares 0%
Preferred Stock, Shares Authorized 15,000,000 shares 0%
Additional Paid in Capital $8,600,917 USD -0.02%
Preferred Stock, Shares Outstanding 15,000,000 shares 50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%